https://www.selleckchem.com/pr....oducts/crenolanib-cp
The International Parkinson and Movement Disorder Society (MDS) has published research criteria for prodromal Parkinson's disease (pPD), which includes cognitive impairment as a prodromal marker. However, the clinical features of mild cognitive impairment (MCI) in pPD remain unknown. Our study aimed to evaluate the frequency and clinical features of mild cognitive impairment of pPD in the elderly in China. The cross-sectional community-based study recruited 2688 participants aged ≥50years. Subjects were diagnosed with pPD a
Like
Comment
Share
